RNU6-1332P

Across TCGA pan-cancer cohorts, RNU6-1332P RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated RNU6-1332P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6-1332P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1332P expression acts as an unfavorable survival marker.

THCA, SKCM, and LIHC are the cancer types where RNU6-1332P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	OS	Tertile	All	0.173	0.952	<.001	90	view →
SKCM	DFS	Tertile	All	0.016	0.758	<.001	72	view →
LIHC	OS	Tertile	III,IV	0.118	0.615	.003	39	view →
CESC	DFS	Tertile	All	0.173	0.740	.003	36	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
CHOL	OS	Tertile	All	0.154	0.793	.004	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

RNU6-1332P–THCA (OS)

Open the THCA breakdown →